Financial results - ENDOMEDICA S.R.L.

Financial Summary - Endomedica S.r.l.
Unique identification code: 19685690
Registration number: J04/1831/2006
Nace: 8621
Sales - Ron
91.823
Net Profit - Ron
44.463
Employee
2
The most important financial indicators for the company Endomedica S.r.l. - Unique Identification Number 19685690: sales in 2023 was 91.823 euro, registering a net profit of 44.463 euro and having an average number of 2 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala generala having the NACE code 8621.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Endomedica S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 22.103 26.086 28.954 31.881 44.485 46.801 48.188 70.247 81.866 91.823
Total Income - EUR 22.103 26.093 28.956 31.881 44.485 46.801 48.190 70.250 81.868 91.825
Total Expenses - EUR 16.271 21.428 18.222 22.070 25.437 24.437 24.543 28.411 33.137 46.582
Gross Profit/Loss - EUR 5.833 4.665 10.734 9.810 19.048 22.364 23.647 41.839 48.731 45.244
Net Profit/Loss - EUR 5.169 3.882 10.444 9.492 18.604 21.896 23.202 41.137 47.966 44.463
Employees 2 2 2 2 2 2 2 2 2 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 12.5%, from 81.866 euro in the year 2022, to 91.823 euro in 2023. The Net Profit decreased by -3.357 euro, from 47.966 euro in 2022, to 44.463 in the last year.

Check the financial reports for the company - Endomedica S.r.l.

Rating financiar

Financial Rating -
Endomedica S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Endomedica S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Endomedica S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Endomedica S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Endomedica S.r.l. - CUI 19685690

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 7.747 6.242 4.933 22.544 18.373 14.559 29.823 31.371 23.375 15.294
Current Assets 9.417 14.137 7.843 4.912 27.861 29.503 11.388 27.485 43.299 80.826
Inventories 0 0 0 0 0 0 0 0 0 0
Receivables 0 0 2.185 0 752 17.328 1.356 3.422 760 1.315
Cash 9.417 14.137 5.658 4.912 27.109 12.175 10.032 24.063 42.539 79.511
Shareholders Funds 13.525 17.520 10.489 19.803 38.043 21.938 27.725 49.714 47.028 91.348
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 3.639 2.859 2.287 7.653 8.191 22.124 13.486 9.142 19.647 4.772
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8621 - 8621"
CAEN Financial Year 8690
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 80.826 euro in 2023 which includes Inventories of 0 euro, Receivables of 1.315 euro and cash availability of 79.511 euro.
The company's Equity was valued at 91.348 euro, while total Liabilities amounted to 4.772 euro. Equity increased by 44.463 euro, from 47.028 euro in 2022, to 91.348 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Endomedica S.r.l.

Comments - Endomedica S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.